Date published: 2026-6-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

YadA Inhibitors

YadA inhibitors belong to a unique class of chemical compounds designed to target the YadA protein, which is primarily found in certain pathogenic bacteria. YadA, short for "Yersinia adhesin A," is a surface protein expressed by bacteria belonging to the Yersinia genus, such as Yersinia enterocolitica and Yersinia pseudotuberculosis. This protein plays a crucial role in the initial stages of host-pathogen interactions, as it functions as an adhesin and invasin, allowing the bacterium to adhere to host cells and facilitate its entry into the host organism. YadA is a significant virulence factor and contributes to the pathogenicity of these bacteria, making it an attractive target for the development of inhibitors.

YadA inhibitors are designed to disrupt the interaction between the YadA protein and host cells. These chemical compounds are typically small molecules that can bind to specific regions of the YadA protein, thereby blocking its adhesion to host cell receptors. By inhibiting this crucial step in the infection process, YadA inhibitors impedes the ability of Yersinia bacteria to establish infections and cause diseases in the host. The development of YadA inhibitors represents a promising avenue in the field of anti-infective research, as it offers a strategy to combat Yersinia infections at their root, by targeting a fundamental aspect of the pathogen's virulence. This class of compounds is the subject of ongoing research aimed at better understanding their mechanism of action and optimizing their effectiveness in combating Yersinia-associated diseases.

SEE ALSO...

Items 11 to 20 of 23 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

AKT inhibitor interfering with the PI3K/Akt pathway, thus impeding YadA expression and function.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Natural product that modulates multiple signaling pathways, potential anti-cancer agent.

Perifosine

157716-52-4sc-364571
sc-364571A
5 mg
10 mg
$188.00
$327.00
1
(2)

AKT inhibitor targeting the PI3K/Akt pathway, leading to suppression of downstream signaling pathways that regulate YadA.

Captopril

62571-86-2sc-200566
sc-200566A
1 g
5 g
$49.00
$91.00
21
(1)

ACE inhibitor, used to lower blood pressure in hypertension.

BEZ235

915019-65-7sc-364429
50 mg
$211.00
8
(1)

Dual PI3K/mTOR inhibitor affecting the PI3K/Akt/mTOR pathway, causing inhibition of YadA expression and function.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

PI3K inhibitor impacting the PI3K/Akt pathway, leading to suppression of downstream signaling cascades regulating YadA.

Donepezil

120014-06-4sc-279006
10 mg
$74.00
3
(1)

Acetylcholinesterase inhibitor, improves cognitive function in Alzheimer′s disease.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules, disrupting cell division in cancer chemotherapy.

AZD5363

1143532-39-1sc-503190
5 mg
$309.00
(0)

AKT inhibitor disrupting the PI3K/Akt pathway, ultimately suppressing YadA expression and function.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Selective BRAF kinase inhibitor, used in melanoma with BRAF mutations.